Transcatheter Mitral Valve Therapy: Defining the Patient Who Will Benefit
Recommended Citation
Eng MH, Wang DD. Transcatheter mitral valve therapy: Defining the patient who will benefit. Curr Cardiol Rep. Sep 12 2018;20(11):107.
Document Type
Article
Publication Date
9-12-2018
Publication Title
Current cardiology reports
Abstract
PURPOSE OF REVIEW: This report aims to define the clinical and anatomic variables key in determining patient suitability for transcatheter mitral valve therapies.
RECENT FINDINGS: Candidacy for transcatheter mitral valve repair requires weighing the clinical variables that may impact the ability to improve patient symptoms and prolong survival that include left ventricular ejection fraction, symptom severity, pulmonary hypertension, and magnitude of residual regurgitation or stenosis. Individualized selection of transcatheter repair or replacement based on patho-anatomy is being explored. The primary goal is achieving significant reduction in mitral regurgitation. Transcatheter mitral valve replacement requires rigorous anatomic screening using computed tomography and candidates should be able to take oral anticoagulation. Selection of patients for transcatheter mitral valve repair is complex and requires intimate knowledge of clinical variables and specific device limitations.
PubMed ID
30209638
Volume
20
Issue
11
First Page
107
Last Page
107
